4//SEC Filing
aTYR PHARMA INC 4
Accession 0001209191-16-090176
$ATYRCIK 0001339970operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 8:25 PM ET
Size
5.6 KB
Accession
0001209191-16-090176
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blackburn Stan
Acting Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2016-01-04+5,754→ 5,754 totalExercise: $9.13→ Common Stock (5,754 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable, if at all, in 48 equal monthly installments upon the achievement of certain performance goals, which must be achieved by January 4, 2018, or such option will be subject to immediate forfeiture. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001339970
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 8:25 PM ET
- Size
- 5.6 KB